{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:37:36Z","timestamp":1772555856415,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003065","name":"University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although there is a very high comorbidity between tobacco dependence and other addictive disorders, there are only few studies examining the implementation and outcomes of a tobacco cessation program in patients with addictive diseases. Therefore, the aim of this study is to investigate to what extent a standardized tobacco cessation program leads to improvements regarding psychological\/physical parameters in patients with addiction undergoing therapy and whether there is a reduction in tobacco consumption.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study took place in a therapeutic community specialized in addiction therapy. A total sample of 56 participants were non-randomly assigned to an intervention group (IG; <jats:italic>n<\/jats:italic>\u2009=\u200931) and a treatment as usual group (TAUG; <jats:italic>n<\/jats:italic>\u2009=\u200925). The IG participated in a 6-week tobacco cessation program, while the TAUG received no additional treatment. Both groups were assessed for changes in primary outcomes (tobacco dependence, smoked cigarettes per day (CPD), and general substance-related craving) and secondary outcomes (heart rate variability (HRV): root mean square of successive differences, self-efficacy, and comorbid psychiatric symptoms) at two measurement time points (pre- and post-treatment\/6\u00a0weeks).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We observed significant improvements in self-efficacy (<jats:italic>F<\/jats:italic><jats:sub>(1,53)<\/jats:sub>\u2009=\u20095.86; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.05; <jats:italic>\u03b7<\/jats:italic><jats:sub><jats:italic>p<\/jats:italic><\/jats:sub><jats:sup>2<\/jats:sup>\u2009=\u2009.11) and decreased CPD in the IG (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20091.16, <jats:italic>\u03c1<\/jats:italic>\u2009&lt;\u2009.05), while no significant changes were observed in the TAUG. No significant interaction effects were observed in psychiatric symptoms, general substance-related craving, and HRV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results highlight the potential benefit of an additional tobacco cessation program as part of a general addiction treatment. Although no improvements in the physiological domain were observed, there were significant improvements regarding self-efficacy and CPD in the IG compared to the TAUG. Randomized controlled trials on larger samples would be an important next step.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ISRCTN15684371<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-024-03405-z","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:06:29Z","timestamp":1714575989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effectiveness of a standardized tobacco cessation program on psychophysiological parameters in patients with addiction undergoing long-term rehabilitation: a quasi-experimental pilot study"],"prefix":"10.1186","volume":"22","author":[{"given":"J.","family":"Fuchshuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sch\u00f6ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wohlmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Senra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schwerdtfeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4815-0214","authenticated-orcid":false,"given":"H. F.","family":"Unterrainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"issue":"2","key":"3405_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/ije\/dyp360","volume":"39","author":"SH Preston","year":"2010","unstructured":"Preston SH, Glei DA, Wilmoth JR. A new method for estimating smoking-attributable mortality in high-income countries. Int J Epidemiol. 2010;39(2):430\u20138.","journal-title":"Int J Epidemiol"},{"key":"3405_CR2","volume-title":"Epidemiologiebericht Sucht 2022. Illegale Drogen, Alkohol und Tabak","author":"J Anzenberger","year":"2022","unstructured":"Anzenberger J, Busch M, Klein C, Priebe B, Schmutterer I, Strizek J. Epidemiologiebericht Sucht 2022. Illegale Drogen, Alkohol und Tabak. Wien: Gesundheit \u00d6sterreich; 2022."},{"issue":"6","key":"3405_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ntr\/ntr048","volume":"13","author":"J Guydish","year":"2011","unstructured":"Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011;13(6):401\u201311.","journal-title":"Nicotine Tob Res"},{"key":"3405_CR4","doi-asserted-by":"publisher","first-page":"106112","DOI":"10.1016\/j.addbeh.2019.106112","volume":"99","author":"MA Parker","year":"2019","unstructured":"Parker MA, Sigmon SC, Villanti AC. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses. Addict Behav. 2019;99:106112.","journal-title":"Addict Behav"},{"issue":"1\u20132","key":"3405_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/0954026021000045949","volume":"15","author":"M Farrell","year":"2003","unstructured":"Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, Marsden J, Taylor C, Meltzer H. Nicotine, alcohol and drug dependence, and psychiatric comorbidity\u2013results of a national household survey. Int Rev Psychiatry. 2003;15(1\u20132):50\u20136.","journal-title":"Int Rev Psychiatry"},{"issue":"5","key":"3405_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/acps.13601","volume":"148","author":"L Balbuena","year":"2023","unstructured":"Balbuena L, Peters E, Speed D. Using polygenic risk scores to investigate the evolution of smoking and mental health outcomes in UK biobank participants. Acta Psychiatr Scand. 2023;148(5):447\u201356.","journal-title":"Acta Psychiatr Scand"},{"issue":"01","key":"3405_CR7","first-page":"914","volume":"10","author":"S M\u00fchlig","year":"2009","unstructured":"M\u00fchlig S. Tabakentw\u00f6hnung bei Patienten mit psychiatrischer St\u00f6rung. Suchttherapie. 2009;10(01):914.","journal-title":"Suchttherapie"},{"key":"3405_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addbeh.2016.10.012","volume":"65","author":"K McKelvey","year":"2017","unstructured":"McKelvey K, Thrul J, Ramo D. Impact of quitting smoking and smoking cessation treatment on substance use outcomes: an updated and narrative review. Addict Behav. 2017;65:161\u201370.","journal-title":"Addict Behav"},{"issue":"3","key":"3405_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2105\/AJPH.2006.101147","volume":"98","author":"JJ Prochaska","year":"2008","unstructured":"Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, Rosen AB, Meisner M, Humfleet GL, Gorecki JA. Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public Health. 2008;98(3):446\u20138.","journal-title":"Am J Public Health"},{"issue":"10","key":"3405_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4088\/JCP.v57n1005","volume":"57","author":"KB Stage","year":"1996","unstructured":"Stage KB, Glassman AH, Covey LS. Depression after smoking cessation. J Clin Psychiatry. 1996;57(10):467\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"3405_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0740-5472(97)00191-8","volume":"15","author":"PE Caldwell","year":"1998","unstructured":"Caldwell PE, Cutter HS. Alcoholics Anonymous affiliation during early recovery. J Subst Abuse Treat. 1998;15(3):221\u20138.","journal-title":"J Subst Abuse Treat"},{"issue":"1\u20132","key":"3405_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1300\/J020v24n01_04","volume":"24","author":"AB Laudet","year":"2006","unstructured":"Laudet AB, Morgen K, White WL. The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-step fellowships in quality of life satisfaction among individuals in recovery from alcohol and drug problems. Alcohol Treat Q. 2006;24(1\u20132):33\u201373.","journal-title":"Alcohol Treat Q"},{"key":"3405_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-14-304","volume":"14","author":"C Cookson","year":"2014","unstructured":"Cookson C, Strang J, Ratschen E, Sutherland G, Finch E, McNeill A. Smoking and its treatment in addiction services: clients\u2019 and staff behaviour and attitudes. BMC Health Serv Res. 2014;14:1\u20138.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"3405_CR14","first-page":"228","volume":"29","author":"DM Ziedonis","year":"2006","unstructured":"Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006;29(3):228.","journal-title":"Alcohol Res Health"},{"issue":"1\u20133","key":"3405_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugalcdep.2007.06.014","volume":"92","author":"SS Fu","year":"2008","unstructured":"Fu SS, Kodl M, Willenbring M, Nelson DB, Nugent S, Gravely AA, Joseph AM. Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment. Drug Alcohol Depend. 2008;92(1\u20133):61\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3405_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1037\/a0013529","volume":"23","author":"CJ Gwaltney","year":"2009","unstructured":"Gwaltney CJ, Metrik J, Kahler CW, Shiffman S. Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav. 2009;23(1):56.","journal-title":"Psychol Addict Behav"},{"key":"3405_CR17","doi-asserted-by":"crossref","first-page":"494340","DOI":"10.3389\/fpsyt.2020.00786","volume":"11","author":"G De Leon","year":"2020","unstructured":"De Leon G, Unterrainer HF. The therapeutic community: A unique social psychological approach to the treatment of addictions and related disorders. Front Psychiatry. 2020;11:494340.","journal-title":"Front Psychiatry"},{"issue":"4","key":"3405_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/10550490902925490","volume":"18","author":"J Chun","year":"2009","unstructured":"Chun J, Haug NA, Guydish JR, Sorensen JL, Delucchi K. Cigarette smoking among opioid-dependent clients in a therapeutic community. Am J Addict. 2009;18(4):316\u201320.","journal-title":"Am J Addict"},{"key":"3405_CR19","doi-asserted-by":"crossref","unstructured":"Moon SJE, Schlenk EA, Lee H. Heart rate variability in adults with substance use disorder: a comprehensive narrative review. J Am Psychiatr Nurses Assoc. (2024;30(2):240\u201351.","DOI":"10.1177\/10783903221145142"},{"key":"3405_CR20","doi-asserted-by":"publisher","first-page":"107502","DOI":"10.1016\/j.drugalcdep.2019.05.030","volume":"204","author":"Y-C Cheng","year":"2019","unstructured":"Cheng Y-C, Huang Y-C, Huang W-L. Heart rate variability as a potential biomarker for alcohol use disorders: a systematic review and meta-analysis. Drug Alcohol Depend. 2019;204:107502.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3405_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijcard.2011.10.140","volume":"163","author":"PC Dinas","year":"2013","unstructured":"Dinas PC, Koutedakis Y, Flouris AD. Effects of active and passive tobacco cigarette smoking on heart rate variability. Int J Cardiol. 2013;163(2):109\u201315.","journal-title":"Int J Cardiol"},{"issue":"6","key":"3405_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.7326\/0003-4819-118-6-199303150-00008","volume":"118","author":"CM van Ravenswaaij-Arts","year":"1993","unstructured":"van Ravenswaaij-Arts CM, Kollee LA, Hopman JC, Stoelinga GB, van Geijn HP. Heart rate variability. Ann Intern Med. 1993;118(6):436\u201347.","journal-title":"Ann Intern Med"},{"key":"3405_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cobeha.2017.12.017","volume":"19","author":"M Mather","year":"2018","unstructured":"Mather M, Thayer JF. How heart rate variability affects emotion regulation brain networks. Curr Opin Behav Sci. 2018;19:98\u2013104.","journal-title":"Curr Opin Behav Sci"},{"key":"3405_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11517-006-0119-0","volume":"44","author":"U Rajendra Acharya","year":"2006","unstructured":"Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS. Heart rate variability: a review. Med Biol Eng Comput. 2006;44:1031\u201351.","journal-title":"Med Biol Eng Comput"},{"key":"3405_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12529-013-9295-0","volume":"21","author":"CB Harte","year":"2014","unstructured":"Harte CB, Meston CM. Effects of smoking cessation on heart rate variability among long-term male smokers. Int J Behav Med. 2014;21:302\u20139.","journal-title":"Int J Behav Med"},{"issue":"9","key":"3405_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0002-9149(97)89203-X","volume":"77","author":"PK Stein","year":"1996","unstructured":"Stein PK, Rottman JN, Kleiger RE. Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability. Am J Cardiol. 1996;77(9):701\u20135.","journal-title":"Am J Cardiol"},{"issue":"1","key":"3405_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/01.HYP.33.1.586","volume":"33","author":"J Minami","year":"1999","unstructured":"Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999;33(1):586\u201390.","journal-title":"Hypertension"},{"issue":"6","key":"3405_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0002-8703(98)70065-1","volume":"135","author":"M Yotsukura","year":"1998","unstructured":"Yotsukura M, Koide Y, Fujii K, Tomono Y, Katayama A, Ando H, Suzuki J, Ishikawa K. Heart rate variability during the first month of smoking cessation. Am Heart J. 1998;135(6):1004\u20139.","journal-title":"Am Heart J"},{"key":"3405_CR29","unstructured":"Dilling H, Mombour W, Schmidt M.H. Internationale Klassifikation psychischer St\u00f6rungen ICD-10, Kapitel V (F): Klinisch-diagnostische Leitlinien [International Classification of Diseases ICD-10]. Bern: Verlag Hans Huber; 2005."},{"key":"3405_CR30","doi-asserted-by":"crossref","unstructured":"Batra A, Buchkremer G. Nichtrauchen!: Erfolgreich aussteigen in sechs Schritten.\u00a0Stuttgart: Stuttgart Kohlhammer Verlag; 2017.","DOI":"10.17433\/978-3-17-033692-6"},{"key":"3405_CR31","unstructured":"Rauchfreiapp [https:\/\/rauchfreiapp.at\/]."},{"key":"3405_CR32","unstructured":"Rauchfrei Telefon [https:\/\/rauchfrei.at\/]."},{"key":"3405_CR33","doi-asserted-by":"crossref","unstructured":"Derogatis LR. Brief symptom inventory 18.\u00a0Baltimore: Johns Hopkins University Baltimore; 2001.","DOI":"10.1037\/t07502-000"},{"issue":"9","key":"3405_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119\u201327.","journal-title":"Br J Addict"},{"issue":"1","key":"3405_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ntr\/ntr137","volume":"14","author":"K Fagerstr\u00f6m","year":"2011","unstructured":"Fagerstr\u00f6m K. Determinants of tobacco use and renaming the FTND to the Fagerstr\u00f6m Test for Cigarette Dependence. Nicotine Tob Res. 2011;14(1):75\u20138.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"3405_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0306-4603(94)90049-3","volume":"19","author":"CS Pomerleau","year":"1994","unstructured":"Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav. 1994;19(1):33\u20139.","journal-title":"Addict Behav"},{"issue":"2","key":"3405_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-2008-1067546","volume":"36","author":"H Nakovics","year":"2008","unstructured":"Nakovics H, Diehl A, Geiselhart H, Mann K. Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS). Psychiatr Prax. 2008;36(2):72\u20138.","journal-title":"Psychiatr Prax"},{"key":"3405_CR38","unstructured":"Schwarzer R, Jerusalem M. Skalen zur Erfassung von Lehrer- und Sch\u00fclermerkmalen. Dokumentation der psychometrischen Verfahren im Rahmen der Wissenschaftlichen Begleitung des Modellversuchs Selbstwirksame Schulen. Berlin: Freie Universit\u00e4t Berlin; 1999."},{"key":"3405_CR39","unstructured":"Tarvainen MP, Lipponen J, Niskanen JP, Ranta-aho PO. Kubios HRV software user\u2019s guide version 3.5. Kubios Oy. 2021.."},{"issue":"3536","key":"3405_CR40","first-page":"514","volume":"134","author":"J Sztajzel","year":"2004","unstructured":"Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly. 2004;134(3536):514\u201322.","journal-title":"Swiss Med Wkly"},{"key":"3405_CR41","doi-asserted-by":"publisher","first-page":"290215","DOI":"10.3389\/fpubh.2017.00258","volume":"5","author":"F Shaffer","year":"2017","unstructured":"Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:290215.","journal-title":"Front Public Health"},{"issue":"1","key":"3405_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1542-474X.2005.10101.x","volume":"10","author":"RE Kleiger","year":"2005","unstructured":"Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10(1):88\u2013101.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"9","key":"3405_CR43","doi-asserted-by":"publisher","first-page":"e0138921","DOI":"10.1371\/journal.pone.0138921","volume":"10","author":"ML Munoz","year":"2015","unstructured":"Munoz ML, Van Roon A, Riese H, Thio C, Oostenbroek E, Westrik I, de Geus EJ, Gansevoort R, Lefrandt J, Nolte IM. Validity of (ultra-) short recordings for heart rate variability measurements. PLoS One. 2015;10(9):e0138921.","journal-title":"PLoS One"},{"key":"3405_CR44","unstructured":"Parsons N. Repolr: An R package for fitting proportional-odds models to repeated ordinal scores, 2017. Avalible from: https:\/\/CRAN.R-project.org\/package=repolr."},{"issue":"1","key":"3405_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41562-016-0021","volume":"1","author":"MR Munaf\u00f2","year":"2017","unstructured":"Munaf\u00f2 MR, Nosek BA, Bishop DV, Button KS, Chambers CD. Percie du Sert N, Simonsohn U, Wagenmakers E-J, Ware JJ, Ioannidis J: A manifesto for reproducible science. Nat Hum Behav. 2017;1(1):1\u20139.","journal-title":"Nat Hum Behav"},{"issue":"Suppl_2","key":"3405_CR46","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1080\/1462220021000032735","volume":"4","author":"KP Richter","year":"2002","unstructured":"Richter KP, McCool RM, Okuyemi KS, Mayo MS, Ahluwalia JS. Patients\u2019 views on smoking cessation and tobacco harm reduction during drug treatment. Nicotine Tob Res. 2002;4(Suppl_2):S175\u201382.","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"3405_CR47","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/add.14969","volume":"115","author":"N Black","year":"2020","unstructured":"Black N, Eisma MC, Viechtbauer W, Johnston M, West R, Hartmann-Boyce J, Michie S, de Bruin M. Variability and effectiveness of comparator group interventions in smoking cessation trials: a systematic review and meta-analysis. Addiction. 2020;115(9):1607\u201317.","journal-title":"Addiction"},{"key":"3405_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ypmed.2016.07.013","volume":"92","author":"PH Smith","year":"2016","unstructured":"Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex\/gender differences in smoking cessation: a review. Prev Med. 2016;92:135\u201340.","journal-title":"Prev Med"},{"issue":"1","key":"3405_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000331007","volume":"18","author":"M Malivert","year":"2011","unstructured":"Malivert M, Fats\u00e9as M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2011;18(1):1\u201311.","journal-title":"Eur Addict Res"},{"key":"3405_CR50","doi-asserted-by":"publisher","first-page":"427817","DOI":"10.1155\/2013\/427817","volume":"2013","author":"W Vanderplasschen","year":"2013","unstructured":"Vanderplasschen W, Colpaert K, Autrique M, Rapp RC, Pearce S, Broekaert E, Vandevelde S. Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. ScientificWorldJournal. 2013;2013:427817.","journal-title":"ScientificWorldJournal."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03405-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03405-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03405-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:17:18Z","timestamp":1714576638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03405-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3405"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03405-z","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with the recommendations of the ethics guidelines of the Medical University of Graz. The study was approved by the ethics committee of Karl-Franzens-University Graz (GZ. GZ. 39\/30\/63 ex 2022\/23).All subjects gave written informed consent to take part in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}